Report Detail

Request for Sample of this report

Other Global Menopausal Hormone Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4561776
    • |
  • 21 October, 2023
    • |
  • Global
    • |
  • 110 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Menopausal Hormone Therapy market size was valued at USD 24180 million in 2022 and is forecast to a readjusted size of USD 35970 million by 2029 with a CAGR of 5.8% during review period.
Menopausal hormone therapy (MHT) is a treatment that uses hormones to relieve the symptoms of menopause. Menopause is a natural process that occurs when a woman's ovaries stop producing estrogen and progesterone. This can cause a variety of symptoms, including hot flashes, night sweats, vaginal dryness, mood swings, and difficulty sleeping.
The menopausal hormone therapy (MHT) market is expected to grow significantly in the coming years, driven by a number of factors, including:
Rising awareness of the benefits of menopausal hormone therapy: There is a growing awareness of the benefits of menopausal hormone therapy, such as relief of menopausal symptoms, reduced risk of osteoporosis, and improved cardiovascular health. This is also driving the demand for menopausal hormone therapy.
Changing social norms: Social norms are changing around menopause, and women are becoming more open to discussing their symptoms and seeking treatment. This is also driving the demand for menopausal hormone therapy.
The North American region is expected to be the largest market for menopausal hormone therapy, followed by Europe and the Asia Pacific region. The growth of the market in the North American region is being driven by the high prevalence of menopause and the easy availability of menopausal hormone therapy products.
Overall, the menopausal hormone therapy market is expected to grow significantly in the coming years, driven by increasing population of menopausal women, rising awareness of the benefits of menopausal hormone therapy, and changing social norms.
The Global Info Research report includes an overview of the development of the Menopausal Hormone Therapy industry chain, the market status of Hospital (Estrogen, Progesterone), Clinic (Estrogen, Progesterone), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Menopausal Hormone Therapy.
Regionally, the report analyzes the Menopausal Hormone Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Menopausal Hormone Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Menopausal Hormone Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Menopausal Hormone Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Estrogen, Progesterone).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Menopausal Hormone Therapy market.
Regional Analysis: The report involves examining the Menopausal Hormone Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Menopausal Hormone Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Menopausal Hormone Therapy:
Company Analysis: Report covers individual Menopausal Hormone Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Menopausal Hormone Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Menopausal Hormone Therapy. It assesses the current state, advancements, and potential future developments in Menopausal Hormone Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Menopausal Hormone Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Menopausal Hormone Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Estrogen
Progesterone
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Menopausal Hormone Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Menopausal Hormone Therapy, with revenue, gross margin and global market share of Menopausal Hormone Therapy from 2018 to 2023.
Chapter 3, the Menopausal Hormone Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Menopausal Hormone Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Menopausal Hormone Therapy.
Chapter 13, to describe Menopausal Hormone Therapy research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Menopausal Hormone Therapy
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Menopausal Hormone Therapy by Type
    • 1.3.1 Overview: Global Menopausal Hormone Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Menopausal Hormone Therapy Consumption Value Market Share by Type in 2022
    • 1.3.3 Estrogen
    • 1.3.4 Progesterone
  • 1.4 Global Menopausal Hormone Therapy Market by Application
    • 1.4.1 Overview: Global Menopausal Hormone Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Menopausal Hormone Therapy Market Size & Forecast
  • 1.6 Global Menopausal Hormone Therapy Market Size and Forecast by Region
    • 1.6.1 Global Menopausal Hormone Therapy Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Menopausal Hormone Therapy Market Size by Region, (2018-2029)
    • 1.6.3 North America Menopausal Hormone Therapy Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Menopausal Hormone Therapy Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Menopausal Hormone Therapy Market Size and Prospect (2018-2029)
    • 1.6.6 South America Menopausal Hormone Therapy Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Menopausal Hormone Therapy Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Eli Lilly
    • 2.1.1 Eli Lilly Details
    • 2.1.2 Eli Lilly Major Business
    • 2.1.3 Eli Lilly Menopausal Hormone Therapy Product and Solutions
    • 2.1.4 Eli Lilly Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Eli Lilly Recent Developments and Future Plans
  • 2.2 Pfizer
    • 2.2.1 Pfizer Details
    • 2.2.2 Pfizer Major Business
    • 2.2.3 Pfizer Menopausal Hormone Therapy Product and Solutions
    • 2.2.4 Pfizer Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Pfizer Recent Developments and Future Plans
  • 2.3 AbbVie
    • 2.3.1 AbbVie Details
    • 2.3.2 AbbVie Major Business
    • 2.3.3 AbbVie Menopausal Hormone Therapy Product and Solutions
    • 2.3.4 AbbVie Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 AbbVie Recent Developments and Future Plans
  • 2.4 Novo Nordisk
    • 2.4.1 Novo Nordisk Details
    • 2.4.2 Novo Nordisk Major Business
    • 2.4.3 Novo Nordisk Menopausal Hormone Therapy Product and Solutions
    • 2.4.4 Novo Nordisk Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Novo Nordisk Recent Developments and Future Plans
  • 2.5 Merck KGaA
    • 2.5.1 Merck KGaA Details
    • 2.5.2 Merck KGaA Major Business
    • 2.5.3 Merck KGaA Menopausal Hormone Therapy Product and Solutions
    • 2.5.4 Merck KGaA Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Merck KGaA Recent Developments and Future Plans
  • 2.6 Mylan
    • 2.6.1 Mylan Details
    • 2.6.2 Mylan Major Business
    • 2.6.3 Mylan Menopausal Hormone Therapy Product and Solutions
    • 2.6.4 Mylan Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Mylan Recent Developments and Future Plans
  • 2.7 Bayer
    • 2.7.1 Bayer Details
    • 2.7.2 Bayer Major Business
    • 2.7.3 Bayer Menopausal Hormone Therapy Product and Solutions
    • 2.7.4 Bayer Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Bayer Recent Developments and Future Plans
  • 2.8 Teva
    • 2.8.1 Teva Details
    • 2.8.2 Teva Major Business
    • 2.8.3 Teva Menopausal Hormone Therapy Product and Solutions
    • 2.8.4 Teva Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Teva Recent Developments and Future Plans
  • 2.9 Novartis
    • 2.9.1 Novartis Details
    • 2.9.2 Novartis Major Business
    • 2.9.3 Novartis Menopausal Hormone Therapy Product and Solutions
    • 2.9.4 Novartis Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Novartis Recent Developments and Future Plans
  • 2.10 Abbott
    • 2.10.1 Abbott Details
    • 2.10.2 Abbott Major Business
    • 2.10.3 Abbott Menopausal Hormone Therapy Product and Solutions
    • 2.10.4 Abbott Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Abbott Recent Developments and Future Plans
  • 2.11 Roche
    • 2.11.1 Roche Details
    • 2.11.2 Roche Major Business
    • 2.11.3 Roche Menopausal Hormone Therapy Product and Solutions
    • 2.11.4 Roche Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Roche Recent Developments and Future Plans
  • 2.12 Endo International
    • 2.12.1 Endo International Details
    • 2.12.2 Endo International Major Business
    • 2.12.3 Endo International Menopausal Hormone Therapy Product and Solutions
    • 2.12.4 Endo International Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Endo International Recent Developments and Future Plans
  • 2.13 Ipsen
    • 2.13.1 Ipsen Details
    • 2.13.2 Ipsen Major Business
    • 2.13.3 Ipsen Menopausal Hormone Therapy Product and Solutions
    • 2.13.4 Ipsen Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Ipsen Recent Developments and Future Plans
  • 2.14 ANI Pharmaceuticals
    • 2.14.1 ANI Pharmaceuticals Details
    • 2.14.2 ANI Pharmaceuticals Major Business
    • 2.14.3 ANI Pharmaceuticals Menopausal Hormone Therapy Product and Solutions
    • 2.14.4 ANI Pharmaceuticals Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 ANI Pharmaceuticals Recent Developments and Future Plans
  • 2.15 TherapeuticsMD
    • 2.15.1 TherapeuticsMD Details
    • 2.15.2 TherapeuticsMD Major Business
    • 2.15.3 TherapeuticsMD Menopausal Hormone Therapy Product and Solutions
    • 2.15.4 TherapeuticsMD Menopausal Hormone Therapy Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 TherapeuticsMD Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Menopausal Hormone Therapy Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Menopausal Hormone Therapy by Company Revenue
    • 3.2.2 Top 3 Menopausal Hormone Therapy Players Market Share in 2022
    • 3.2.3 Top 6 Menopausal Hormone Therapy Players Market Share in 2022
  • 3.3 Menopausal Hormone Therapy Market: Overall Company Footprint Analysis
    • 3.3.1 Menopausal Hormone Therapy Market: Region Footprint
    • 3.3.2 Menopausal Hormone Therapy Market: Company Product Type Footprint
    • 3.3.3 Menopausal Hormone Therapy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Menopausal Hormone Therapy Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Menopausal Hormone Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Menopausal Hormone Therapy Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Menopausal Hormone Therapy Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Menopausal Hormone Therapy Consumption Value by Type (2018-2029)
  • 6.2 North America Menopausal Hormone Therapy Consumption Value by Application (2018-2029)
  • 6.3 North America Menopausal Hormone Therapy Market Size by Country
    • 6.3.1 North America Menopausal Hormone Therapy Consumption Value by Country (2018-2029)
    • 6.3.2 United States Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Menopausal Hormone Therapy Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Menopausal Hormone Therapy Consumption Value by Type (2018-2029)
  • 7.2 Europe Menopausal Hormone Therapy Consumption Value by Application (2018-2029)
  • 7.3 Europe Menopausal Hormone Therapy Market Size by Country
    • 7.3.1 Europe Menopausal Hormone Therapy Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 7.3.3 France Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Menopausal Hormone Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Menopausal Hormone Therapy Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Menopausal Hormone Therapy Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Menopausal Hormone Therapy Market Size by Region
    • 8.3.1 Asia-Pacific Menopausal Hormone Therapy Consumption Value by Region (2018-2029)
    • 8.3.2 China Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 8.3.5 India Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Menopausal Hormone Therapy Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Menopausal Hormone Therapy Consumption Value by Type (2018-2029)
  • 9.2 South America Menopausal Hormone Therapy Consumption Value by Application (2018-2029)
  • 9.3 South America Menopausal Hormone Therapy Market Size by Country
    • 9.3.1 South America Menopausal Hormone Therapy Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Menopausal Hormone Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Menopausal Hormone Therapy Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Menopausal Hormone Therapy Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Menopausal Hormone Therapy Market Size by Country
    • 10.3.1 Middle East & Africa Menopausal Hormone Therapy Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Menopausal Hormone Therapy Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Menopausal Hormone Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Menopausal Hormone Therapy Market Drivers
  • 11.2 Menopausal Hormone Therapy Market Restraints
  • 11.3 Menopausal Hormone Therapy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Menopausal Hormone Therapy Industry Chain
  • 12.2 Menopausal Hormone Therapy Upstream Analysis
  • 12.3 Menopausal Hormone Therapy Midstream Analysis
  • 12.4 Menopausal Hormone Therapy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Menopausal Hormone Therapy. Industry analysis & Market Report on Menopausal Hormone Therapy is a syndicated market report, published as Global Menopausal Hormone Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Menopausal Hormone Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,735.28
    		4,102.92
    		5,470.56
    		3,215.52
    		4,823.28
    		6,431.04
    		544,898.40
    		817,347.60
    		1,089,796.80
    		289,849.20
    		434,773.80
    		579,698.40
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo